What is the Elimination of Ocrelizumab?
•
3 min read
With a terminal elimination half-life of approximately 26 to 28 days, understanding what is the elimination of ocrelizumab is crucial for comprehending its sustained effects on B-cell depletion. Unlike many small-molecule drugs, this large monoclonal antibody is cleared primarily through catabolism rather than classic hepatic or renal metabolism, a process it shares with the body's own antibodies.
